PROINFLAMMATORY CYTOKINES AND ANGIOGENIC AND ANTI-ANGIOGENIC FACTORS IN VITREOUS OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY AND EALES’ DISEASE

Purpose: To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) and Eales’ disease (ED) on the basis of the levels of proinflammatory cytokines, angiogenic growth factor, and antiangiogenic factor in the vitreous humor. Methods: Twenty-five patients with PDR, 10 patients with ED, and 25 with macular hole (MH) as control subjects were studied. The concentration of the proinflammatory cytokines interleukin-6 (IL-6), IL-8, IL-1&bgr;; chemokine-monocyte chemoattractant protein-1 (MCP-1); angiogenic factor-vascular endothelial growth factor (VEGF); and antiangiogenic factor-pigment epithelium derived factor (PEDF) in the vitreous fluid obtained from the eyes during vitrectomy were measured by sandwich enzyme linked immunosorbent assay (ELISA). Results: IL-6, IL-8, MCP-1, and VEGF levels in the vitreous were significantly higher in PDR (P < 0.0001) and ED (P < 0.0001) than in MH patients. Conversely, the vitreous level of PEDF was significantly reduced in PDR (P < 0.0001) but not in ED. A significant correlation was observed between VEGF and IL-6 in ED patients. Conclusion: The authors demonstrate the importance of VEGF in retinal neovascularization of ED which is an idiopathic inflammatory venous occlusion. Further study is required to understand the interrelationship between VEGF and inflammatory cytokines in PDR and ED.

[1]  M. Matsumura,et al.  Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  H. Yamashita,et al.  Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines , 2007, Eye.

[3]  Stephanie J. Fonda,et al.  Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation , 2007, Nature Medicine.

[4]  S. Sizmaz,et al.  Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy , 2006, Eye.

[5]  V. Mohan,et al.  Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. , 2005, Investigative ophthalmology & visual science.

[6]  P. Campochiaro,et al.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. , 2004, American journal of ophthalmology.

[7]  H. Yamashita,et al.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. , 2003, Ophthalmology.

[8]  S. Yoshida,et al.  Role of MCP‐1 and MIP‐1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization , 2003, Journal of leukocyte biology.

[9]  M. Matsumura,et al.  Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. , 2002, American journal of ophthalmology.

[10]  M. Boulton,et al.  The pathogenesis of diabetic retinopathy: old concepts and new questions , 2002, Eye.

[11]  A. Adamis,et al.  Is diabetic retinopathy an inflammatory disease? , 2002, The British journal of ophthalmology.

[12]  L. Atmaca,et al.  A long-term follow-up of Eales’ disease , 2002, Ocular immunology and inflammation.

[13]  Y. Tagawa,et al.  Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy , 2001, Ophthalmologica.

[14]  S. Kishi,et al.  Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. , 2001, Journal of diabetes and its complications.

[15]  H. Dua,et al.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy , 2001, The British journal of ophthalmology.

[16]  Jian-xing Ma,et al.  Unbalanced expression of VEGF and PEDF in ischemia‐induced retinal neovascularization , 2001, FEBS letters.

[17]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[18]  B. Mukesh,et al.  Profiling of human leukocyte antigens in Eales‘ disease , 1997, International Ophthalmology.

[19]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[20]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[21]  A. Reder,et al.  Cytokines in the vitreous of patients with proliferative diabetic retinopathy. , 1992, American journal of ophthalmology.

[22]  I. Morita,et al.  IL-6 increases endothelial permeability in vitro. , 1992, Endocrinology.

[23]  B. Ghosh,et al.  Serum alpha‐1 acid glycoprotein levels in patients with idiopathic peripheral retinal vasculitis (Eales' disease) , 1992, Acta ophthalmologica.

[24]  K. Rengarajan,et al.  Immunological status of patients of Eales' disease. , 1989, The Indian journal of medical research.

[25]  M. Davis,et al.  Diabetic retinopathy. A clinical overview. , 1988, Diabetes care.

[26]  J. Rosenbaum,et al.  Ocular inflammatory effects of intravitreal interleukin 1. , 1987, Archives of ophthalmology.

[27]  H. Yamashita,et al.  Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  P. Donders.  Eales' disease , 2004, Documenta Ophthalmologica.

[29]  M. Tamai,et al.  Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases. , 2001, Japanese journal of ophthalmology.

[30]  J. Folkman,et al.  Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .

[31]  R. Strieter,et al.  Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. , 1995, Current eye research.

[32]  J. Caro,et al.  Hypoxia regulatory elements of the human vascular endothelial growth factor gene. , 1994, Cellular & molecular biology research.

[33]  Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[34]  R. Klein,et al.  Visual impairment in diabetes. , 1984, Ophthalmology.

[35]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .